Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia
- PMID: 12885746
- DOI: 10.1161/01.CIR.0000083725.72693.EA
Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia
Abstract
Background: Although catheter mapping has been used to define the endocardial electrogram characteristics in patients with ventricular tachycardia (VT) and coronary disease, characterization of the electrophysiological substrate in patients with VT and nonischemic cardiomyopathy is limited.
Methods and results: Left ventricular endocardial electroanatomical mapping was performed in 19 patients with nonischemic cardiomyopathy and monomorphic VT with an average of 178+/-83 sites per chamber mapped. Abnormal bipolar electrogram was defined as endocardial voltage signal amplitude of <1.8 mV. The extent and location of abnormal endocardium was estimated by measuring areas of abnormal electrogram recordings from 3D voltage maps. The origin of VT was approximated by identifying sites of entrainment with concealed fusion or early presystolic activity and/or by pace mapping. Abnormal electrograms were recorded over a 41+/-28 cm2 area that represented 20+/-12% of total endocardial surface. The majority of patients (14/19 patients) had only a modest area (<25%) of endocardial abnormality. All patients had abnormal low-voltage endocardial areas located near the ventricular base in the perivalvular region. There were 3+/-1 VT morphologies per patient. The majority (88%) of the 57 mapped VTs originated from the ventricular base, corresponding to regions with abnormal endocardial electrograms.
Conclusions: Electroanatomical mapping in patients with monomorphic VT and nonischemic cardiomyopathy typically demonstrates a modest-sized basal area of endocardial electrogram abnormalities. The VT site of origin corresponds to these basal electrogram abnormalities. These findings have important implications regarding strategies for VT ablation in this setting.
Similar articles
-
Electroanatomic substrate and outcome of catheter ablative therapy for ventricular tachycardia in setting of right ventricular cardiomyopathy.Circulation. 2004 Oct 19;110(16):2293-8. doi: 10.1161/01.CIR.0000145154.02436.90. Epub 2004 Oct 11. Circulation. 2004. PMID: 15477406
-
Endocardial substrate mapping for monomorphic ventricular tachycardia ablation in ischemic and non-ischemic cardiomyopathy.Kobe J Med Sci. 2008 Jul 18;54(2):E122-35. Kobe J Med Sci. 2008. PMID: 18772614
-
Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: the importance of low-voltage scars.J Am Coll Cardiol. 2004 May 19;43(10):1834-42. doi: 10.1016/j.jacc.2004.01.029. J Am Coll Cardiol. 2004. PMID: 15145109
-
Electroanatomic mapping of the endocardium. Implication for catheter ablation of ventricular tachycardia.Herz. 2003 Nov;28(7):583-90. doi: 10.1007/s00059-003-2492-x. Herz. 2003. PMID: 14689118 Review.
-
Three-dimensional myocardial scar characterization from the endocardium: Usefulness of endocardial unipolar electroanatomic mapping.J Cardiovasc Electrophysiol. 2019 Mar;30(3):427-437. doi: 10.1111/jce.13842. Epub 2019 Jan 12. J Cardiovasc Electrophysiol. 2019. PMID: 30614100 Review.
Cited by
-
Outcomes of Catheter Ablation of Ventricular Tachycardia in the Setting of Structural Heart Disease.Curr Cardiol Rep. 2016 Jul;18(7):68. doi: 10.1007/s11886-016-0742-9. Curr Cardiol Rep. 2016. PMID: 27234813 Review.
-
Ablation of ventricular fibrillation and tachycardia.Curr Cardiol Rep. 2005 Sep;7(5):342-8. doi: 10.1007/s11886-005-0087-2. Curr Cardiol Rep. 2005. PMID: 16105489 Review.
-
Management of ventricular arrhythmias in heart failure: Current perspectives.Heart Rhythm O2. 2021 Dec 17;2(6Part B):796-806. doi: 10.1016/j.hroo.2021.08.007. eCollection 2021 Dec. Heart Rhythm O2. 2021. PMID: 34988531 Free PMC article.
-
Interventional Pericardiology.Curr Cardiol Rep. 2016 Mar;18(3):31. doi: 10.1007/s11886-016-0698-9. Curr Cardiol Rep. 2016. PMID: 26908116 Review.
-
Opportunities and Challenges in Catheter-Based Irreversible Electroporation for Ventricular Tachycardia.Pathophysiology. 2024 Jan 10;31(1):32-43. doi: 10.3390/pathophysiology31010003. Pathophysiology. 2024. PMID: 38251047 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical